Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14231643 | 0.94 | RAB9A (0.50) | TDP1RAB9AALDH1A1NPC1MAPT | |
| P-Xylene SCHEMBL28358132 | 0.93 | ALDH1A1 (0.59) | TDP1RAB9AALDH1A1NPC1MAPT | |
| Ethylene Glycol SCHEMBL3446601 | 0.92 | TDP1 (0.55) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL206554 | 0.90 | TDP1 (0.61) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL26378 | 0.89 | TDP1 (0.56) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL16900467 | 0.89 | RAB9A (0.49) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL28228923 | 0.89 | RAB9A (0.49) | TDP1RAB9AALDH1A1NPC1MAPT | |
| SCHEMBL11593251 | 0.88 | CA1 (0.66) | TDP1RAB9AALDH1A1NPC1MAPT | |
| Acetone SCHEMBL28904622 | 0.88 | TSHR (0.55) | TDP1RAB9AALDH1A1NPC1MAPT | |
| Lithium SCHEMBL30805733 | 0.87 | TDP1 (0.54) | TDP1RAB9AALDH1A1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1910532-B1 | USE OF ESTERASES FOR SEPARATING PLASTICS | HENKEL AG & CO KGAA (DE) | 2011-07-20 | — | — | EP | claimed |
| US-12031128-B2 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | BATTELLE MEMORIAL INSTITUTE (US) | 2024-07-09 | — | — | US | disclosed |
| US-12031128-B2 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | BATTELLE MEMORIAL INSTITUTE (US) | 2024-07-09 | — | — | US | disclosed |
| CN-112135598-B | Macromer-based photocurable dental impression material | 登士柏希罗纳有限公司 | 2023-12-22 | — | — | CN | disclosed |
| US-20220175812-A1 | POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY | BATTELLE MEMORIAL INSTITUTE | 2022-06-09 | — | — | US | disclosed |
| WO-2022120194-A1 | POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY | BATTELLE MEMORIAL INSTITUTE (US) | 2022-06-09 | — | — | WO | disclosed |
| US-10475546-B2 | Conductors comprising a functionalized organosiloxane network and methods for the preparation thereof | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2019-11-12 | — | — | US | disclosed |
| US-10295882-B2 | Display device | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2019-05-21 | — | — | US | disclosed |
| US-9487631-B2 | Surface active polymeric systems | UNIVERSITY OF DURHAM (GB) | 2016-11-08 | — | — | US | disclosed |
| US-8846070-B2 | Biologically degradable compositions for medical applications | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2014-09-30 | — | — | US | disclosed |
| US-20090286098-A1 | Optical Film, Method of Producing the Same and Image Displaying Apparatus Employing the Optical Film | KONICA MINOLTA OPTO, INC. (JP) | 2009-11-19 | — | — | US | disclosed |
| US-20090258406-A1 | Use of esterases for separating plastics | HENKEL KGAA (DE) | 2009-10-15 | — | — | US | disclosed |
| US-20090135345-A1 | Polarizing Plate Protective Film, Film Producing Method, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2009-05-28 | — | — | US | disclosed |
| US-7229987-B2 | Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes | ELI LILLY AND COMPANY (US) | 2007-06-12 | — | — | US | disclosed |
| US-7229987-B2 | Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes | ELI LILLY AND COMPANY (US) | 2007-06-12 | — | — | US | disclosed |
| US-20070046872-A1 | Liquid crystal display | KONICA MINOLTA OPTO, INC. | 2007-03-01 | — | — | US | disclosed |
| US-20060280882-A1 | Cellulose ester film, polarizing plate and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2006-12-14 | — | — | US | disclosed |
| US-20060202366-A1 | Optical film, manufacturing method of optical film, optical compensating film, manufacturing method of optical compensating film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. | 2006-09-14 | — | — | US | disclosed |
| US-20060078754-A1 | Optical film, polarizing plate and display | KONICA MINOLTA OPTO, INC. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-20060060997-A1 | Polarizing plate protective film and manufacturing method for the same | KONICA MINOLTA OPTO, INC. | 2006-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12031128-B2 | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers | PHAX, POLRMT, RFTN1 | TDP1 158/4885RAB9A 2708/4885ALDH1A1 3308/4885 |
| US-20220175812-A1 | POLYMER NANOPARTICLE AND DNA NANOSTRUCTURE COMPOSITIONS AND METHODS FOR NON-VIRAL DELIVERY | POLN, POLRMT, MAVS | TDP1 260/4885RAB9A 2730/4885ALDH1A1 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.